Cannabis cultivator Beleave inks $20 mln facility with Alumina
Beleave Inc, a Toronto-based cultivator and seller of medical cannabis and producer of cannabis oils and extracts, has secured an investment of up to $20 million from U.S. private equity firm Alumina Partners. Under the deal's terms, Beleave will be able to draw down capital as needed in a series of private placements of a minimum of $2 million. The proceeds will be used by the company to take advantage of new opportunities in the regulated cannabis sector, increase operating flexibility, and strengthen its balance sheet. Beleave is led by CEO Andrew Wnek.
17 September 2018•3 mins read
